Position
Essential Partners LLC in Sutro Biopharma, Inc.
Back to the book · All holders of STRO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $43$0.87 → $11.50
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q2 2025 | 654 | $467 | — | — | — | 0.0% |
| Q3 2025 | 212 | $184 | $0.87 | $33 | −$316 | 0.0% |
| Q4 2025 | 4 | $46 | $11.50 | $43 | −$181 | 0.0% |